Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function
- PMID: 17950813
- DOI: 10.1016/j.amjcard.2007.06.042
Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function
Abstract
Ultrasound contrast has shown to improve endocardial border definition. The purpose of this study was to evaluate the value of contrast agent-enhanced versus non-contrast agent-enhanced real-time 3-dimensional echocardiography (RT3DE) for the assessment of left ventricular (LV) volumes and ejection fraction. Thirty-nine unselected patients underwent RT3DE with and without SonoVue contrast agent enhancement and magnetic resonance imaging (MRI) on the same day. An image quality index was calculated by grading all 16 individual LV segments on a scale of 0 to 4: 0, not visible; 1, poor; 2, moderate; 3, good; and 4, excellent. The 3-dimensional data sets were analyzed offline using dedicated TomTec analysis software. By manual tracing, LV end-systolic volume, LV end-diastolic volume, and LV ejection fraction were calculated. After contrast agent enhancement, mean image quality index improved from 2.4 +/- 1.0 to 3.0 +/- 0.9 (p <0.001). Contrast agent-enhanced RT3DE measurements showed better correlation with MRI (LV end-diastolic volume, r = 0.97 vs 0.86; LV end-systolic volume, r = 0.96 vs 0.94; LV ejection fraction, r = 0.94 vs 0.81). The limits of agreement (Bland-Altman analysis) showed a similar bias for RT3DE images with and without contrast agent but with smaller limits of agreement for contrast agent-enhanced RT3DE. Also, inter- and intraobserver variabilities decreased. In a subgroup, patients with poor to moderate image quality showed an improvement in agreement after administration of contrast agent (+/-24.4% to +/-12.7%) to the same level as patients with moderate to good image quality without contrast agent (+/-10.4%). In conclusion, contrast agent-enhanced RT3DE is more accurate in assessment of LV function as evidenced by better correlation and narrower limits of agreement compared with MRI, as well as lower intra- and interobserver variabilities.
Similar articles
-
[Assessment of global and regional left ventricular function with a 16-slice spiral-CT using two different software tools for quantitative functional analysis and qualitative evaluation of wall motion changes in comparison with magnetic resonance imaging].Rofo. 2004 Dec;176(12):1786-93. doi: 10.1055/s-2004-813730. Rofo. 2004. PMID: 15573290 German.
-
New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance.Eur J Echocardiogr. 2006 Oct;7(5):365-72. doi: 10.1016/j.euje.2005.09.005. Epub 2006 Aug 17. Eur J Echocardiogr. 2006. PMID: 16916621
-
Diagnostic value of three-dimensional contrast-enhanced echocardiography for left ventricular volume and ejection fraction measurement in patients with poor acoustic windows: a comparison of echocardiography and magnetic resonance imaging.J Am Soc Echocardiogr. 2014 Oct;27(10):1029-40. doi: 10.1016/j.echo.2014.06.006. Epub 2014 Jul 23. J Am Soc Echocardiogr. 2014. PMID: 25063466 Clinical Trial.
-
Myocardial contrast echocardiography for the assessment of left ventricular function.Minerva Cardioangiol. 2003 Dec;51(6):661-6. Minerva Cardioangiol. 2003. PMID: 14676751 Review.
-
[Possibilities and limits of 2-dimensional echocardiography in quantitative image analysis].Z Kardiol. 1989;78 Suppl 7:131-42. Z Kardiol. 1989. PMID: 2696247 Review. German.
Cited by
-
Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.J Cancer Surviv. 2014 Jun;8(2):183-9. doi: 10.1007/s11764-013-0326-2. Epub 2013 Dec 7. J Cancer Surviv. 2014. PMID: 24317971 Free PMC article.
-
Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications.Neth Heart J. 2011 Oct;19(10):423-31. doi: 10.1007/s12471-011-0160-y. Neth Heart J. 2011. PMID: 21584798 Free PMC article.
-
Clinical application of three-dimensional echocardiography: past, present and future.Neth Heart J. 2009 Jan;17(1):18-24. doi: 10.1007/BF03086210. Neth Heart J. 2009. PMID: 19148334 Free PMC article.
-
Clinical uses of microbubbles in diagnosis and treatment.Med Biol Eng Comput. 2009 Aug;47(8):813-26. doi: 10.1007/s11517-009-0434-3. Epub 2009 Feb 10. Med Biol Eng Comput. 2009. PMID: 19205774 Review. No abstract available.
-
Current clinical applications of transthoracic three-dimensional echocardiography.J Cardiovasc Ultrasound. 2012 Mar;20(1):1-22. doi: 10.4250/jcu.2012.20.1.1. Epub 2012 Mar 27. J Cardiovasc Ultrasound. 2012. PMID: 22509433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources